Rapport Therapeutics, Inc. RAPP Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s operating lease right-of-use asset amortization?
- Rapport Therapeutics, Inc. (RAPP) reported operating lease right-of-use asset amortization of $582K in Q1 2026.
- How has Rapport Therapeutics, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- Rapport Therapeutics, Inc.'s operating lease right-of-use asset amortization increased by 41.6% year-over-year, from $411K to $582K.